XXXX , mortality over time and mortality relative to other @entity385 .

@entity26186 @entity64 @entity1188 @entity385
OBJECTIVES: Determine the overall mortality after @entity1188 and compare it to the overall mortality afterothrombotic and @entity64 . Determine the pattern of increased mortality over time after @entity1188 . METHODS: The clinical literature was searched for articles providing mortality data on @entity1188 having at least 5 years of @entity64 follow up. Three such articles were identified two of which also had @entity64 mortality data on the other two types of @entity385 , atherothrombotic and @entity64 . Degree of overall increased mortality was determined for all three @entity64 types and increased mortality over time was determined for @entity1188 as well. Standard mortality methodology was used and expectant mortality was determined using appropriate population life tables. Average overall mortality ratios (MR) and average overall excess deaths per thousand per year ( @entity26186 ) were determined by weighting for the number of entrants in each study. RESULTS: The average overall MR for @entity1188 = 159%, for @entity64 = 213% and for @entity64 = 322%. The mortality ratios for @entity1188 for the following post- @entity64 intervals were: 1-5 years = 166%; 6-10 years = 153%; and 11-14 years = 106%. CONCLUSIONS: @entity1188 from onset is associated with moderately increased overall mortality relative to the general population. Post- @entity64 mortality risks from atherothrombotic and @entity64 are significantly higher.
